Best Grants for Cancer Nonprofits in Missouri

The ASTRO-AstraZeneca SCLC Therapy Challenge RFP aims to enhance research on limited-stage small cell lung cancer (LS-SCLC) through innovative combination therapies, particularly integrating immunotherapy with advanced radiation techniques. Proposals are encouraged to explore various aspects, including care patterns, treatment workflows, prognostic biomarkers, and toxicity management. The target budget for projects ranges from $175,000 to $375,000, with consideration given to higher requests based on scientific merit, fostering significant advancements in radiation oncology.

The RFA: Biology to Prevention Award (CRUK) aims to foster innovative translational research that enhances understanding of cancer biology, ultimately leading to effective prevention strategies. Joint applications from UK and US research teams are encouraged, with a focus on equal partnerships and complementary expertise. The funding provides up to £600,000 for UK costs and up to $946,000 for US costs, supporting projects of 1 to 5 years duration that address critical research questions in cancer prevention.

The Anna Fuller Fund Grant provides year-round support for organizations dedicated to alleviating suffering caused by cancer. Established in memory of Egbert C. Fuller’s wife, the fund prioritizes applications that focus on cancer research and education initiatives. Eligible applicants must be 501(c)(3) organizations or equivalent charities outside the U.S. Grant funds cannot be used for direct treatment, ensuring that resources are allocated to research and public education.

The James Paul Sutton Medical Research Fund Grant supports non-profit organizations engaged in cancer and medical research, established through a trust by the Sutton family. Eligible organizations must be 501(c)(3) exempt. Preference is given to cancer research initiatives, while grants are not available for individuals, political groups, or for-profit entities. This fund aims to sustain medical research efforts for the long term, continuing the legacy of the Sutton family.

The National Cancer Institute (NCI) plans to issue a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12). This program aims to enhance training for clinician-scientists in cancer research, fostering their career development and collaboration with basic research scientists. It mandates diverse oncology specialties in faculty, individualized career development plans, and mentorship, supporting Scholars for up to three years to promote their research initiatives in clinical trials.

The Simeon J. Fortin Charitable Foundation, founded in 1986, champions cancer research initiatives aimed at finding a cure. It supports relevant projects and fellowships within medical and research institutions, ensuring a significant impact on health-related research. The grant review process is conducted by The Medical Foundation, in coordination with the King Trust Postdoctoral Fellowships, enhancing collaboration and funding opportunities for innovative research in oncology.

The AGD Foundation Grant Program supports nonprofit organizations in the U.S. and Canada that provide free oral cancer screenings and education, particularly for underserved communities. Established in 1972, the AGD Foundation aims to enhance public oral health and raise awareness about oral/oropharyngeal cancer. By promoting early detection and education, the foundation seeks to improve survival rates and empower communities. Eligible applicants must be 501(c)(3) organizations demonstrating a commitment to community health.

The EMF SAMFund Financial Assistance Grants support young adult cancer survivors facing financial hardships due to their diagnosis. With 80,000 young adults diagnosed with cancer each year in the U.S., these grants provide critical assistance for essential living expenses like rent, car payments, and education. By prioritizing applicants who demonstrate financial need and articulate how the grant will aid their recovery, the program aims to alleviate financial toxicity and empower survivors to move forward with their lives.

The EMF Family Building Grants, offered by the Expect Miracles Foundation, support young adult cancer survivors in their fertility treatment and family-building efforts. These grants are designed for applicants with a clear family-building plan and financial strategy, helping bridge the gap in costs associated with fertility preservation, assisted reproductive technologies, and related services. By prioritizing those actively engaged in their journey, the foundation aims to empower survivors to pursue their dreams of family.

Patients in Missouri being treated for Waldenstrom macroglobulinemia can apply for Healthwell Foundation’s Waldenstrom Macroglobulinemia Fund, which offers up to US $8,000 for prescription drug copays and Medicare Part B premiums. Eligible applicants must be underinsured, meet income guidelines, have qualifying insurance, and receive treatment in the U.S.

Cancer researchers at U.S. academic institutions or eligible nonprofits, including those in Missouri, can seek more than US $135,000 for high-risk, high-reward translational projects focused on Fanconi anemia–related cancers. Grants from American Cancer Society and Fanconi Cancer Foundation support innovative work in early detection, prevention, and tailored therapies for FA-associated tumors.

Patients in Missouri with mantle cell lymphoma who are underinsured can receive up to US $8,500 to offset prescription drug copays and Medicare Part B insurance premiums. Grants from Healthwell Foundation help cover medications used to treat mantle cell lymphoma, easing financial barriers to cancer care for eligible individuals treated in the U.S.

Underinsured individuals in the U.S. being treated for chronic lymphocytic leukemia can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums. With a mission to reduce financial barriers to care, Healthwell Foundation provides support that Missouri cancer nonprofits can share with eligible patients they serve.

Individuals being treated in Missouri for cancer-related behavioral health conditions who are underinsured can receive up to US $2,000 to offset prescription drug copays, counseling, psychotherapy, and related transportation costs. Healthwell Foundation provides this assistance to U.S. patients whose treatment is covered by insurance and whose income meets its financial guidelines.

Underinsured U.S. patients being treated for amyloidosis can receive up to US $8,000 to cover prescription drug copays and Medicare Part B insurance premiums. HealthWell Foundation bases eligibility on diagnosis, insurance coverage, and income, and Missouri cancer and oncology patients meeting these criteria may benefit from this assistance for covered treatments.

Professional elderly blues musicians facing emergency medical or living expenses can receive US $500 in assistance for care, transportation, treatments, utilities, or burial costs across the U.S. Cancer nonprofits in Missouri may connect eligible artists they serve to this Pinetop Perkins Foundation program for crisis support related to cancer or other serious conditions.

With a mission to improve patient-centered healthcare, the Patient-Centered Outcomes Research Institute provides Missouri cancer and oncology organizations with up to US $13,000,000 for comparative clinical effectiveness research across the cancer care continuum. Eligible public and private sector organizations must form researcher-community partnerships to address screening barriers, treatment quality, or survivorship needs in U.S. populations.

Missouri cancer and health research organizations can access funding through the Patient-Centered Outcomes Research Institute for retrospective observational comparative clinical effectiveness research using existing data sources. Eligible private, public, U.S., and foreign institutions must address at least one PCORI topic theme, such as cancer, maternal morbidity, mental health, pain, substance use, rare diseases, or metabolic and endocrine health, with awards up to US $2,000,000.

Cancer research institutions conducting translational oncology studies, including those in Missouri, can seek funding to run P50 SPORE research centers advancing prevention, early detection, diagnosis, and treatment of human cancers. National Institutes of Health, through the National Cancer Institute, offers US $25,000,000 to support multi-year, organ-specific or mechanism-based clinical trial programs.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support, including certifications and conferences. Heart of Illinois Community Foundation’s scholarship may benefit cancer-focused organizations whose staff meet these criteria and reside in Macon, Moultrie, or Piatt County.

Full-time radiation oncology faculty clinicians conducting cancer research in Missouri can seek multi-year career development support through this clinician scientist award, which offers US $135,000 annually. Focused on advancing cancer and radiation oncology research careers, the American Society for Radiation Oncology and American Cancer Society co-fund this grant for U.S.-based academic or eligible nonprofit institutions.

Practicing radiation oncologists in the U.S., including those based in Missouri, can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years for cancer research. Hospital- or clinic-affiliated cancer programs may benefit when their clinicians receive this support for oncology research across the cancer continuum.

Missouri cancer and healthcare organizations such as hospitals, medical schools, patient advocacy groups, and eligible 501(c)(3) nonprofits can access funding through Incyte for programs that provide healthcare information and support patients with cancer and other diseases. Grants, charitable contributions, and sponsorships support medical education, professional training, and patient care initiatives that meet Incyte’s compliance guidelines.

Cancer-focused medical schools, hospitals, patient advocacy groups, and other eligible nonprofits in Missouri can seek funding for healthcare information initiatives, education, and patient services. Focused on cancer and other diseases, Incyte supports programs that help students, healthcare providers, patients, caregivers, and advocates access critical healthcare information through charitable contributions, sponsorships, and memberships.

The CDC's initiative focuses on developing clinical decision support (CDS) tools for cancer screening and management, specifically for cervical, breast, and colorectal cancers. The project aims to enhance guideline-concordant screening and improve management processes through rigorous implementation and evaluation within large health systems. By integrating these tools into electronic health records, the initiative seeks to support clinicians in making evidence-based decisions at the point of care, ultimately improving patient outcomes in cancer care.

The Health Promotion and Disease Prevention Research Centers are offering supplemental funding for Special Interest Projects (SIPs) aimed at enhancing public health practices. These projects will focus on innovative health promotion and disease prevention strategies to mitigate leading health risks in the U.S. The initiative supports ten specific SIPs, including studies on cancer care, alcohol use reduction, and emergency preparedness, thereby fostering research that translates into real-world health improvements.

The National Cancer Institute (NCI) is set to release a Notice of Funding Opportunity (NOFO) aimed at advancing informatics technologies for cancer research. This initiative will support the development of tools that enhance data acquisition, management, and analysis throughout the cancer continuum. By focusing on technologies with proven impact, the NOFO seeks to optimize and sustain resources critical for cancer biology, diagnosis, treatment, and epidemiology.